|
1
|
Working Group For National Survey On
Status Of Diagnosis And Treatment Of Childhood Renal Diseases, .
Multicenter survey of diagnostic and therapeutic status in Chinese
childhood patients with steroid-sensitive,
relaping/steroid-dependent nephrotic syndrome. Zhonghua Er Ke Za
Zhi. 52:194–200. 2014.(In Chinese). PubMed/NCBI
|
|
2
|
Brenner BM, Hostetter TH and Humes HD:
Glomerular permselectivity: Barrier function based on
discrimination of molecular size and charge. Am J Physiol.
234:F455–F460. 1978.PubMed/NCBI
|
|
3
|
Bridges CR, Myers BD, Brenner BM and Deen
WM: Glomerular charge alterations in human minimal change
nephropathy. Kidney Int. 22:677–684. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miner JH: Renal basement membrane
components. Kidney Int. 56:2016–2024. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yamada T and Kawasaki T: Microbial
synthesis of hyaluronan and chitin: New approaches. J Biosci
Bioeng. 99:521–528. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Davies JA, Fisher CE and Barnett MW:
Glycosaminoglycans in the study of mammalian organ development.
Biochem Soc Trans. 29:166–171. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cengiz N, Bayazit AK, Noyan A, Anarat R
and Anarat A: Glycosaminoglycan excretion in children with
nephrotic syndrome. Pediatr Nephrol. 20:486–490. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Carrie BJ, Salyer WR and Myers BD: Minimal
change nephropathy: An electrochemical disorder of the glomerular
membrane. Am J Med. 70:262–268. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Baggio B, Gambaro G, Briani G, Favaro S
and Borsatti A: Urinary excretion of glycosaminoglycans and brush
border and lysosomal enzymes as a marker of glomerular and tubular
involvement in kidney disease. Contrib Nephrol. 42:107–110. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hotz P, Pilliod J, Berode M, Rey F and
Boillat MA: Glycosaminoglycans, albuminuria and hydrocarbon
exposure. Nephron. 58:184–191. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu XM, Wang Z and Guo Y: Respiratory
syncytial virus nephropathy in rats. Kidney Int. 71:388–396. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Klebanoff SJ, Kinsella MG and Wight TN:
Degradation of endothelial cell matrix heparan sulfate proteoglycan
by elastase and the
myeloperoxidase-H2O2-chloride system. Am J
Pathol. 143:907–917. 1993.PubMed/NCBI
|
|
13
|
Baggio B and Gambaro G: Antiproteinuric
effect of glycosaminoglycans? Nephron. 64:643–644. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vehaskari VM, Root ER, Germuth FG Jr and
Robson AM: Glomerular charge and urinary protein excretion: Effect
of systemic and intrarenal polycation infusion in the rat. Kidney
Int. 22:127–135. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen S-J, Zhang S-W, Wei M, Xiong Y, Gao
Y, Hu Y, et al: Glycosaminoglycans on CRP and UAER of early
diabetic nephropathy. Zhong Guo Lao Nian Xue Za Zhi. 27:1779–1781.
2007.(In Chinese).
|
|
16
|
Lever R and Page CP: Novel drug
development opportunities for heparin. Nat Rev Drug Discov.
1:140–148. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
PAGE CP: One explanation of the asthma
paradox: Inhibition of natural anti-inflammatory mechanism by beta
2-agonists. Lancet. 337:717–720. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Brown RA, Leung E, Kankaanranta H,
Moilanen E and Page CP: Effects of heparin and related drugs on
neutrophil function. Pulm Pharmacol Ther. 25:185–192. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Birmele B, Thibault G, Nivet H, de
Agostini A and Girardin EP: In vitro decrease of glomerular heparan
sulfate by lymphocytes from idiopathic nephrotic syndrome patients.
Kidney Int. 59:913–922. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Salant DJ: The structural biology of
glomerular epithelialcells in proteinuric diseases. Curr Opin
Nephrol Hypertens. 3:569–574. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vernier RL, Klein DJ, Sisson SP, Mahan JD,
Oegema TR and Brown DM: Heparan sulphate-rich anionic sites in the
human glomerular basement membrane. Decreased concentration in
congenital nephrotic syndrome. N Engl J Med. 309:1001–1009. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Girardin EP, Birmele B, Benador N, Neuhaus
T, Hosseini G, Van Den Heuvel LP and De Agostini A: Effect of
plasma from patients with idiopathic nephrotic syndrome on
proteoglycan synthesis by human and rat glomerular cells. Pediatr
Res. 43:489–495. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mitsuhashi H, Tsukada Y, Ono K, Yano S and
Naruse T: Urine glycosaminoglycans and heparan sulfate excretions
in adult patients with glomerular diseases. Clin Nephrol.
39:231–238. 1993.PubMed/NCBI
|
|
24
|
Heeringa P, van den Born J, Brouwer E,
Dolman KM, Klok PA, Huitema MG, Limburg PC, Bakker MA, Berden JH,
Daha MR and Kallenberg CG: Elastase, but not proteinase 3 (PR3),
induces proteinuria associated with loss of glomerular basement
membrane heparan sulphate after in vivo renal perfusion in rats.
Clin Exp Immunol. 105:321–329. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guo Y, Wang Z, Dong L, Wu J, Zhai S and
Liu D: Ability of low-molecular-weight heparin to alleviate
proteinuria by inhibiting respiratory syncytial virus infection.
Nephrology (Carlton). 13:545–553. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tao YH, Wang Z and Zhou YR: Expression of
heparanase in kidney of rats with respiratory syncytial virus
nephropathy and its relationship with proteinurina. Sichuan Da Xue
Xue Bao Yi Xue Ban. 45:212–224. 2014.(In Chinese). PubMed/NCBI
|
|
27
|
Dong LQ, Wang XQ, Guo YN, Wu J, Li S, Yu P
and Wang Z: HS N-sulfation and iduronic acids play an important
role in the infection of respiratory syncytial virus in vitro. Eur
Rev Med Pharmacol Sci. 17:1864–1868. 2013.PubMed/NCBI
|
|
28
|
Brown RA, Lever R, Jones NA and Page CP:
Effects of heparin and related molecules upon neutrophil
aggregation and elastase release in vitro. Br J Pharmacol.
139:845–853. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cadène M, Boudier C, de Marcillac GD and
Bieth JG: Influence of low molecular mass heparin on the kinetics
of neutrophil elastase inhibition by mucus proteinase inhibitor. J
Biol Chem. 270:13204–13209. 1995. View Article : Google Scholar : PubMed/NCBI
|
